<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37881302</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2633-4402</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>NIHR open research</Title><ISOAbbreviation>NIHR Open Res</ISOAbbreviation></Journal><ArticleTitle>The remote diet intervention to reduce Long COVID symptoms trial (ReDIRECT): protocol for a randomised controlled trial to determine the effectiveness and cost-effectiveness of a remotely delivered supported weight management programme for people with Long COVID and excess weight, with personalised improvement goals.</ArticleTitle><Pagination><StartPage>57</StartPage><MedlinePgn>57</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">57</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3310/nihropenres.13315.2</ELocationID><Abstract><AbstractText Label="OBJECTVES" NlmCategory="UNASSIGNED">The Remote Diet Intervention to Reduce Long COVID Symptoms Trial (ReDIRECT) evaluates whether the digitally delivered, evidence-based, cost-effective Counterweight-Plus weight management programme improves symptoms of Long COVID in people with overweight/obesity.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Baseline randomised, non-blinded design with 240 participants allocated in a 1:1 ratio either to continue usual care or to add the remotely delivered Counterweight-Plus weight management programme, which includes a Counterweight dietitian supported delivery of 12 weeks total diet replacement, food reintroduction, and long-term weight loss maintenance. Randomisation is achieved by accessing a web-based randomisation system incorporated into the study web portal developed by a registered Clinical Trials Unit. We are using an innovative approach to outcome personalisation, with each participant selecting their most dominant Long COVID symptom as their primary outcome assessed at six months. Participants in the control arm enter the weight management programme after six months. We are recruiting participants from social media and existing networks (e.g., Long COVID Scotland groups), through newspaper advertisements and from primary care. Main inclusion criteria: people with Long COVID symptoms persisting &gt; three months, aged 18 years or above, body mass index (BMI) above 27kg/m <sup>2</sup> (&gt;25kg/m <sup>2</sup> for South Asians). The trial includes a process evaluation (involving qualitative interviews with participants and analysis of data on dose, fidelity and reach of the intervention) and economic evaluation (within-trial and long-term cost-utility analyses).</AbstractText><AbstractText Label="ANTICIPATED RESULTS" NlmCategory="UNASSIGNED">The recruitment for this study started in December 2021 and ended in July 2022. Project results are not yet available and will be shared via peer-reviewed publication once the six-months outcomes have been analysed.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">Current Controlled Trials ISRCTN12595520.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Haag L et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haag</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3342-1365</Identifier><AffiliationInfo><Affiliation>Human Nutrition, School of Medicine, Dentistry &amp; Nursing, University of Glasgow, Glasgow, G31 2ER, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Janice</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8207-0891</Identifier><AffiliationInfo><Affiliation>School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunningham</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7533-8933</Identifier><AffiliationInfo><Affiliation>General Practice &amp; Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, G12 9LX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brosnahan</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Counterweight Ltd., London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibbotson</LastName><ForeName>Tracy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9224-6467</Identifier><AffiliationInfo><Affiliation>General Practice &amp; Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, G12 9LX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ormerod</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Long COVID Scotland, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Long COVID Scotland, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntosh</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6340-3083</Identifier><AffiliationInfo><Affiliation>Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Practice &amp; Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, G12 9LX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sattar</LastName><ForeName>Naveed</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McConnachie</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Robertson Centre for Biostatistics, University of Glasgow, Glasgow, G12 8QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lean</LastName><ForeName>Michael E J</ForeName><Initials>MEJ</Initials><AffiliationInfo><Affiliation>Human Nutrition, School of Medicine, Dentistry &amp; Nursing, University of Glasgow, Glasgow, G31 2ER, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blane</LastName><ForeName>David N</ForeName><Initials>DN</Initials><Identifier Source="ORCID">0000-0002-3872-3621</Identifier><AffiliationInfo><Affiliation>General Practice &amp; Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, G12 9LX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combet</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9302-8971</Identifier><AffiliationInfo><Affiliation>Human Nutrition, School of Medicine, Dentistry &amp; Nursing, University of Glasgow, Glasgow, G31 2ER, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.21270837.v4</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NIHR Open Res</MedlineTA><NlmUniqueID>9918333281906676</NlmUniqueID><ISSNLinking>2633-4402</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>While most people infected with COVID-19 recover within a short amount of time, some people continue to have symptoms for 12 weeks or longer. This condition is known as Long COVID. Roughly two-thirds of people with Long COVID are overweight, a proportion similar to that found in the general population. Being overweight may worsen symptoms such as fatigue, breathlessness and pains. Weight management programmes in adults with overweight/obesity can reduce such symptoms, however we do not know how effective intentional weight loss is to reduce symptoms for people with Long COVID. The aim of this project is to test a well-established weight management programme, delivered and supported remotely, in people with Long COVID. The trial is conducted with 240 people with Long COVID, identified through their GP, patient groups, social media, or newspaper advertisements. A total of 120 individuals will receive the personalised, professionally supported weight management programme (treatment group), and 120 participants are allocated to usual care (control group). The one-year long weight management programme involves 12 weeks of total diet replacement (TDR) using soups and shakes, followed by food reintroduction and weight maintenance. Food based alternatives are available to those who are unable, or prefer not to, follow the TDR approach. The two groups will be compared for Long COVID symptoms, weight loss, quality of life and value for money after six months. After six months, the weight management programme will also be provided for the control group. Experiences while on the programme will be documented for 12 months for all participants. People with Long COVID have been involved extensively in developing this project. Their priorities are to reduce symptoms like fatigue, breathlessness and pain. They are keen to explore if effective weight management would help their symptoms and overall functioning, especially a programme that can be followed remotely from home. A group of patients and other stakeholders has been set up to provide advice throughout the project.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Haag L et al.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID; Randomised Controlled Trial</Keyword><Keyword MajorTopicYN="N">Personalisation</Keyword><Keyword MajorTopicYN="N">Post COVID-19 Syndrome</Keyword><Keyword MajorTopicYN="N">Remote delivery</Keyword><Keyword MajorTopicYN="N">Total diet replacement</Keyword><Keyword MajorTopicYN="N">Weight management</Keyword></KeywordList><CoiStatement>Competing interests: AM is a member of Clinical Steering Committee for ARC Medical Inc. NS has received institutional grant support from AstraZeneca, Boehringer Ingelheim, Novartis, Roche Diagnostics and honoraria from Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Merck Sharp &amp; Dohme, Novartis, Novo Nordisk, Pfizer, Sanofi ML has consulted for Novo Nordisk, Nestle, Oviva, Merck, Sanofi and is an unpaid medical advisor to Counterweight Ltd. NB is an employee and shareholder of Counterweight Ltd., subcontracted to the University of Glasgow to deliver the ReDIRECT intervention</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>4</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37881302</ArticleId><ArticleId IdType="pmc">PMC10593354</ArticleId><ArticleId IdType="doi">10.3310/nihropenres.13315.2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. : Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucott L, Poobalan A, Smith WCS, et al. : Effects of Weight Loss in Overweight/Obese Individuals and Long-Term Hypertension Outcomes: a systematic review. Hypertension. 2005;45(6):1035&#x2013;1041. 10.1161/01.HYP.0000165680.59733.d4</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000165680.59733.d4</ArticleId><ArticleId IdType="pubmed">15897373</ArticleId></ArticleIdList></Reference><Reference><Citation>Avenell A, Broom J, Brown TJ, et al. : Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8(21):iii&#x2013;iv, 1&#x2013;182. 10.3310/hta8210</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta8210</ArticleId><ArticleId IdType="pubmed">15147610</ArticleId></ArticleIdList></Reference><Reference><Citation>Babb TG, Wyrick BL, Chase PJ, et al. : Weight Loss via Diet and Exercise Improves Exercise Breathing Mechanics in Obese Men. Chest. 2011;140(2):454&#x2013;460. 10.1378/chest.10-1088</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-1088</ArticleId><ArticleId IdType="pubmed">21273293</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L, Vetrani C, Caprio M, et al. : From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID-19 Infection (Post CoVID Syndrome). Curr Obes Rep. 2022;11(3):144&#x2013;165. 10.1007/s13679-022-00475-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-022-00475-z</ArticleId><ArticleId IdType="pmc">PMC9075143</ArticleId><ArticleId IdType="pubmed">35524067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall JC, Paul EA, Garrod R, et al. : Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581&#x2013;586. 10.1136/thx.54.7.581</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchholz I, Janssen MF, Kohlmann T, et al. : A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645&#x2013;661. 10.1007/s40273-018-0642-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-018-0642-5</ArticleId><ArticleId IdType="pmc">PMC5954044</ArticleId><ArticleId IdType="pubmed">29572719</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckell J, Mei XW, Clarke P, et al. : Weight loss interventions on health-related quality of life in those with moderate to severe obesity: Findings from an individual patient data meta-analysis of randomized trials. Obes Rev. 2021;22(11):e13317. 10.1111/obr.13317</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13317</ArticleId><ArticleId IdType="pubmed">34374197</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G, Long Covid Forum Group: Research priorities for Long Covid: refined through an international multi-stakeholder forum. BMC Med. 2021;19(1):84. 10.1186/s12916-021-01947-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01947-0</ArticleId><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, et al. : Development of a fatigue scale. J Psychosom Res. 1993;37(2):147&#x2013;153. 10.1016/0022-3999(93)90081-p</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-p</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, Altman DG, et al. : SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern Med. 2013;158(3):200&#x2013;207. 10.7326/0003-4819-158-3-201302050-00583</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-3-201302050-00583</ArticleId><ArticleId IdType="pmc">PMC5114123</ArticleId><ArticleId IdType="pubmed">23295957</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, et al. : Unexplained post-acute infection syndromes. Nat Med. 2022;28:911&#x2013;923. 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JB, Cohen DL: Cardiovascular and Renal Effects of Weight Reduction in Obesity and the Metabolic Syndrome. Curr Hypertens Rep. 2015;17(5):34. 10.1007/s11906-015-0544-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-015-0544-2</ArticleId><ArticleId IdType="pmc">PMC4427189</ArticleId><ArticleId IdType="pubmed">25833456</ArticleId></ArticleIdList></Reference><Reference><Citation>Combet E, Blane D, Haag L: ReDIRECT study eCRF questionnaires screenshots. figshare. Online resource.2022a. 10.6084/m9.figshare.21270837.v4</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.21270837.v4</ArticleId></ArticleIdList></Reference><Reference><Citation>Combet E, Blane D, Haag L: SPIRIT checklist ReDIRECT study. figshare.Online resource. 2022b. 10.6084/m9.figshare.21404901.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.21404901.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. : Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo A, Petrone-De Luca P, Sasso GF, et al. : Effects of Weight Loss on Body Composition and Pulmonary Function. Respiration. 1999;66(5):407&#x2013;412. 10.1159/000029423</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000029423</ArticleId><ArticleId IdType="pubmed">10516536</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, et al. : Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;775. 10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsythe LK, Wallace JMW, Livingstone MBE: Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008;21(2):117&#x2013;133. 10.1017/S0954422408138732</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0954422408138732</ArticleId><ArticleId IdType="pubmed">19087366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, Piernas C, Astbury NM, et al. : Associations between body-mass index and COVID-19 severity in 6&#xb7;9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9(6):350&#x2013;359. 10.1016/S2213-8587(21)00089-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00089-9</ArticleId><ArticleId IdType="pmc">PMC8081400</ArticleId><ArticleId IdType="pubmed">33932335</ArticleId></ArticleIdList></Reference><Reference><Citation>Husereau D, Drummond M, Augustovski F, et al. : Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. Value Health. 2022;25(1):10&#x2013;31. 10.1016/j.jval.2021.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2021.10.008</ArticleId><ArticleId IdType="pubmed">35031088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lean ME, Leslie WS, Barnes AC, et al. : Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541&#x2013;551. 10.1016/S0140-6736(17)33102-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)33102-1</ArticleId><ArticleId IdType="pubmed">29221645</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong A, Cole JB, Brenner LN, et al. : Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis. PLoS Med. 2021;18(3):e1003553. 10.1371/journal.pmed.1003553</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003553</ArticleId><ArticleId IdType="pmc">PMC7971850</ArticleId><ArticleId IdType="pubmed">33661905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. : More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfliet A, Quiroz Marnef A, Nijs J, et al. : Obesity Hurts: The Why and How of Integrating Weight Reduction With Chronic Pain Management. Phys Ther. 2021;101(11):pzab198. 10.1093/ptj/pzab198</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzab198</ArticleId><ArticleId IdType="pubmed">34403478</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella R, Esposito K, Siniscalchi M, et al. : Effect of Weight Loss on Cardiac Synchronization and Proinflammatory Cytokines in Premenopausal Obese Women. Diabetes Care. 2004;27(1):47&#x2013;52. 10.2337/diacare.27.1.47</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.27.1.47</ArticleId><ArticleId IdType="pubmed">14693965</ArticleId></ArticleIdList></Reference><Reference><Citation>May CR, Mair F, Finch T, et al. : Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci. 2009;4(1):29. 10.1186/1748-5908-4-29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-4-29</ArticleId><ArticleId IdType="pmc">PMC2693517</ArticleId><ArticleId IdType="pubmed">19460163</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. : Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. : Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence: Guide to the methods of technology appraisal 2013.National Institute for Health and Care Excellence,2013;1&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">27905712</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics:
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021.2021.
Reference Source
</Citation></Reference><Reference><Citation>
Office for National Statistics:
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 August 2022.2022.
Reference Source
</Citation></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. : Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly MC, Zbrozek AS, Dukes EM: The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353&#x2013;365. 10.2165/00019053-199304050-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-199304050-00006</ArticleId><ArticleId IdType="pubmed">10146874</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddle DL, Stratford PW: Body weight changes and corresponding changes in pain and function in persons with symptomatic knee osteoarthritis: A cohort study. Arthritis Care Res (Hoboken). 2013;65(1):15&#x2013;22. 10.1002/acr.21692</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.21692</ArticleId><ArticleId IdType="pmc">PMC3401342</ArticleId><ArticleId IdType="pubmed">22505346</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigamonti AE, Cicolini S, Caroli D, et al. : Effects of a 3-Week In-Hospital Body Weight Reduction Program on Cardiovascular Risk Factors, Muscle Performance, and Fatigue: A Retrospective Study in a Population of Obese Adults with or without Metabolic Syndrome. Nutrients. 2020;12(5):1495. 10.3390/nu12051495</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12051495</ArticleId><ArticleId IdType="pmc">PMC7284609</ArticleId><ArticleId IdType="pubmed">32455545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, McInnes IB, McMurray JJV: Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation. 2020;142(1):4&#x2013;6. 10.1161/CIRCULATIONAHA.120.047659</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047659</ArticleId><ArticleId IdType="pubmed">32320270</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, Valabhji J: Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care. Curr Obes Rep. 2021;10(3):282&#x2013;289. 10.1007/s13679-021-00448-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-021-00448-8</ArticleId><ArticleId IdType="pmc">PMC8353061</ArticleId><ArticleId IdType="pubmed">34374955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheu WHH, Chang TM, Lee WJ, et al. : Effect of Weight Loss on Proinflammatory State of Mononuclear Cells in Obese Women. Obesity (Silver Spring). 2008;16(5):1033&#x2013;1038. 10.1038/oby.2008.37</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2008.37</ArticleId><ArticleId IdType="pubmed">18356846</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Gillies CL, Singh R, et al. : Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab. 2020;22(10):1915&#x2013;1924. 10.1111/dom.14124</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14124</ArticleId><ArticleId IdType="pmc">PMC7361304</ArticleId><ArticleId IdType="pubmed">32573903</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadoni G, Stratford P, Solomon P, et al. : Development and Cross-validation of the P4: A Self-Report Pain Intensity Measure. Physiotherapy Canada. 2003;55(1). 10.2310/6640.2003.35217</Citation><ArticleIdList><ArticleId IdType="doi">10.2310/6640.2003.35217</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenius-Aarniala B, Poussa T, Kvarnstr&#xf6;m J, et al. : Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ. 2000;320(7238):827&#x2013;832. 10.1136/bmj.320.7238.827</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.320.7238.827</ArticleId><ArticleId IdType="pmc">PMC27319</ArticleId><ArticleId IdType="pubmed">10731173</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. : Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;1714. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. : Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. : Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Go&#xeb;rtz YMJ, Van Herck M, et al. : Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 2021;7(2):00141&#x2013;02021. 10.1183/23120541.00141-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00141-2021</ArticleId><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilarrasa N, Vendrell J, S&#xe1;nchez-Santos R, et al. : Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67(5):679&#x2013;686. 10.1111/j.1365-2265.2007.02945.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2007.02945.x</ArticleId><ArticleId IdType="pubmed">17608757</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh P, Polisecki E, Robertson M, et al. : Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach. J Clin Endocrinol Metab. 2010;95(1):93&#x2013;99. 10.1210/jc.2009-1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-1064</ArticleId><ArticleId IdType="pmc">PMC2805500</ArticleId><ArticleId IdType="pubmed">19906786</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. : Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C, Lewsey JD, Mackay DF, et al. : Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling. Med Decis Making. 2017;37(4):427&#x2013;439. 10.1177/0272989X16670617</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X16670617</ArticleId><ArticleId IdType="pmc">PMC5424853</ArticleId><ArticleId IdType="pubmed">27698003</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z: Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;321. 10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin Y, Davies A, Briggs A, et al. : Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia. 2020;63(10):2112&#x2013;2122. 10.1007/s00125-020-05224-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-020-05224-2</ArticleId><ArticleId IdType="pmc">PMC7476973</ArticleId><ArticleId IdType="pubmed">32776237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361&#x2013;370. 10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>: Unexplained post-acute infection syndromes. Nat Med .2022;28(5) : 10.1038/s41591-022-01810-6 911-923 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>